Financial Ratios Clinuvel Pharmaceuticals Limited

Revenues

Interest And Invest. Income (Rev)

Other Revenues, Total

Cost of Goods Sold, Total

Selling General & Admin Expenses, Total

Stock-Based Compensation (IS)

R&D Expenses

Depreciation & Amortization - (IS)

Other Operating Expenses

Other Operating Expenses, Total

Interest Expense, Total

Interest And Investment Income

Net Interest Expenses

Currency Exchange Gains (Loss)

Other Non Operating Income (Expenses)

Other Unusual Items

Income Tax Expense

Net Income to Company

Minority Interest

Net Income to Common Incl Extra Items

Net Income to Common Excl. Extra Items

Net EPS - Basic

Basic EPS - Continuing Operations

Basic Weighted Average Shares Outstanding

Net EPS - Diluted

Diluted EPS - Continuing Operations

Diluted Weighted Average Shares Outstanding

Normalized Basic EPS

Normalized Diluted EPS

Dividend Per Share

Payout Ratio

American Depositary Receipts Ratio (ADR)

EBITDA

EBITA

EBIT

EBITDAR

Total Revenues (As Reported)

Effective Tax Rate - (Ratio)

Total Current Taxes

Total Deferred Taxes

Normalized Net Income

Marketing Expenses

Selling and Marketing Expenses

General and Administrative Expenses

Research And Development Expense From Footnotes

Net Rental Expense, Total

Imputed Operating Lease Interest Expense

Imputed Operating Lease Depreciation

Stock-Based Comp., COGS (Total)

Stock-Based Comp., Other (Total)

Total Stock-Based Compensation

Cash And Equivalents

Short Term Investments

Accounts Receivable, Total

Other Receivables

Inventory

Prepaid Expenses

Other Current Assets, Total

Gross Property Plant And Equipment

Accumulated Depreciation

Long-term Investments

Goodwill

Other Intangibles, Total

Deferred Tax Assets Long-Term

Accounts Payable, Total

Accrued Expenses, Total

Current Portion of Leases

Current Income Taxes Payable

Other Current Liabilities

Long-Term Leases

Pension & Other Post Retirement Benefits

Deferred Tax Liability Non Current

Other Non Current Liabilities

Common Stock, Total

Retained Earnings

Comprehensive Income and Other

Total Common Equity

Minority Interest

ECS Total Shares Outstanding on Filing Date

ECS Total Common Shares Outstanding

Book Value / Share

Tangible Book Value

Tangible Book Value Per Share

Total Debt

Net Debt

Debt Equivalent Oper. Leases

Minority Interest, Total (Incl. Fin. Div)

Account Code - Inventory Valuation

Inventories - Raw Materials, Total

Inventories - Work In Process, Total

Inventories - Finished Goods, Total

Land - (BS)

Buildings, Total

Machinery, Total

Accumulated Allowance for Doubtful Accounts (Supple)

Net Income

Depreciation & Amortization - CF

Depreciation & Amortization, Total

(Gain) Loss From Sale Of Asset

Stock-Based Compensation (CF)

Other Operating Activities, Total

Change In Accounts Receivable

Change In Inventories

Change In Accounts Payable

Change In Income Taxes

Change In Deferred Taxes

Change in Other Net Operating Assets

Capital Expenditure

Investment in Marketable and Equity Securities, Total

Long-Term Debt Repaid, Total

Total Debt Repaid

Issuance of Common Stock

Repurchase of Common Stock

Common Dividends Paid

Common & Preferred Stock Dividends Paid

Other Financing Activities, Total

Foreign Exchange Rate Adjustments

Miscellaneous Cash Flow Adjustments

Cash Interest Paid

Cash Income Tax Paid (Refund)

Change In Net Working Capital

Net Debt Issued / Repaid